PER 0.00% 10.0¢ percheron therapeutics limited

Research report, page-12

  1. 4,694 Posts.
    lightbulb Created with Sketch. 1089
    Same here - still reading with a massive smile on my face.

    "It looks like the door is now wide open for Antisense to make its mark in drug development. Most importantly for investors, that means value creation can start to ramp up at incredible rates."
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.